CN104189949B - 一种复方大蓟外用止血海绵及制备方法 - Google Patents
一种复方大蓟外用止血海绵及制备方法 Download PDFInfo
- Publication number
- CN104189949B CN104189949B CN201410406936.4A CN201410406936A CN104189949B CN 104189949 B CN104189949 B CN 104189949B CN 201410406936 A CN201410406936 A CN 201410406936A CN 104189949 B CN104189949 B CN 104189949B
- Authority
- CN
- China
- Prior art keywords
- cirsii japonici
- radix cirsii
- ethanol
- parts
- external
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 229920002472 Starch Polymers 0.000 claims abstract description 27
- 239000008107 starch Substances 0.000 claims abstract description 27
- 235000019698 starch Nutrition 0.000 claims abstract description 27
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000218176 Corydalis Species 0.000 claims abstract description 18
- 229960004919 procaine Drugs 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 83
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000007710 freezing Methods 0.000 claims description 16
- 230000008014 freezing Effects 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 14
- 239000000725 suspension Substances 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 238000003825 pressing Methods 0.000 claims description 8
- 229920000742 Cotton Polymers 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 238000002844 melting Methods 0.000 claims description 7
- 230000008018 melting Effects 0.000 claims description 7
- 238000007654 immersion Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 15
- 230000023597 hemostasis Effects 0.000 abstract description 14
- 208000014674 injury Diseases 0.000 abstract description 11
- 230000000025 haemostatic effect Effects 0.000 abstract description 7
- 229940030225 antihemorrhagics Drugs 0.000 abstract description 6
- 208000001780 epistaxis Diseases 0.000 abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 230000008733 trauma Effects 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 description 26
- 208000032843 Hemorrhage Diseases 0.000 description 23
- 206010052428 Wound Diseases 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 17
- 230000006378 damage Effects 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 208000034158 bleeding Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 206010053615 Thermal burn Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000002439 hemostatic effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 208000009084 Cold Injury Diseases 0.000 description 3
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 238000013475 authorization Methods 0.000 description 3
- 230000002595 cold damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 108010027612 Batroxobin Proteins 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- -1 Iodine molecule ion Chemical class 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- 102000013566 Plasminogen Human genes 0.000 description 2
- 108010051456 Plasminogen Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 210000001699 lower leg Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000009286 sanguis draxonis Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002515 Animal bite Diseases 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- DFOCUWZXJBAUSQ-URLMMPGGSA-N Berbamine Chemical compound C([C@@H]1N(C)CCC=2C=C(C(OC=3C(OC)=C(OC)C=C4CCN(C)[C@@H](C=34)CC=3C=C(C(=CC=3)O)O3)=CC=21)OC)C1=CC=C3C=C1 DFOCUWZXJBAUSQ-URLMMPGGSA-N 0.000 description 1
- DFOCUWZXJBAUSQ-UHFFFAOYSA-N Berbamine Natural products O1C(C(=CC=2)O)=CC=2CC(C=23)N(C)CCC3=CC(OC)=C(OC)C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C1C=C2 DFOCUWZXJBAUSQ-UHFFFAOYSA-N 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010053317 Hydrophobia Diseases 0.000 description 1
- 206010021079 Hypopnoea Diseases 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229960003375 aminomethylbenzoic acid Drugs 0.000 description 1
- QCTBMLYLENLHLA-UHFFFAOYSA-N aminomethylbenzoic acid Chemical compound NCC1=CC=C(C(O)=O)C=C1 QCTBMLYLENLHLA-UHFFFAOYSA-N 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001567 anti-fibrinolytic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000000504 antifibrinolytic agent Substances 0.000 description 1
- 229940082620 antifibrinolytics Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- XSXCZNVKFKNLPR-SDQBBNPISA-N carbazochrome Chemical compound NC(=O)N/N=C/1C(=O)C=C2N(C)CC(O)C2=C\1 XSXCZNVKFKNLPR-SDQBBNPISA-N 0.000 description 1
- 229960002631 carbazochrome Drugs 0.000 description 1
- 229960004353 carbazochrome sodium sulfonate Drugs 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229960004281 desmopressin Drugs 0.000 description 1
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229940056582 human hair preparation Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 125000003071 maltose group Chemical group 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- ZJTLZYDQJHKRMQ-UHFFFAOYSA-N menadiol Chemical compound C1=CC=CC2=C(O)C(C)=CC(O)=C21 ZJTLZYDQJHKRMQ-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- HLFCZZKCHVSOAP-WXIWBVQFSA-M sodium;(5e)-5-(carbamoylhydrazinylidene)-1-methyl-6-oxo-2,3-dihydroindole-2-sulfonate Chemical compound [Na+].NC(=O)N\N=C/1C(=O)C=C2N(C)C(S([O-])(=O)=O)CC2=C\1 HLFCZZKCHVSOAP-WXIWBVQFSA-M 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510290088.XA CN104841003A (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵及其制备工艺 |
CN201510290072.9A CN104857555A (zh) | 2014-08-19 | 2014-08-19 | 复方大蓟外用止血海绵 |
CN201410406936.4A CN104189949B (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵及制备方法 |
CN201510290087.5A CN104840998A (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵的制备方法 |
CN201510290071.4A CN104840997A (zh) | 2014-08-19 | 2014-08-19 | 复方大蓟外用止血海绵的制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410406936.4A CN104189949B (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵及制备方法 |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510290071.4A Division CN104840997A (zh) | 2014-08-19 | 2014-08-19 | 复方大蓟外用止血海绵的制作方法 |
CN201510290072.9A Division CN104857555A (zh) | 2014-08-19 | 2014-08-19 | 复方大蓟外用止血海绵 |
CN201510290088.XA Division CN104841003A (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵及其制备工艺 |
CN201510290087.5A Division CN104840998A (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104189949A CN104189949A (zh) | 2014-12-10 |
CN104189949B true CN104189949B (zh) | 2015-12-02 |
Family
ID=52075407
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410406936.4A Active CN104189949B (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵及制备方法 |
CN201510290072.9A Pending CN104857555A (zh) | 2014-08-19 | 2014-08-19 | 复方大蓟外用止血海绵 |
CN201510290088.XA Pending CN104841003A (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵及其制备工艺 |
CN201510290087.5A Pending CN104840998A (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵的制备方法 |
CN201510290071.4A Pending CN104840997A (zh) | 2014-08-19 | 2014-08-19 | 复方大蓟外用止血海绵的制作方法 |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510290072.9A Pending CN104857555A (zh) | 2014-08-19 | 2014-08-19 | 复方大蓟外用止血海绵 |
CN201510290088.XA Pending CN104841003A (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵及其制备工艺 |
CN201510290087.5A Pending CN104840998A (zh) | 2014-08-19 | 2014-08-19 | 一种复方大蓟外用止血海绵的制备方法 |
CN201510290071.4A Pending CN104840997A (zh) | 2014-08-19 | 2014-08-19 | 复方大蓟外用止血海绵的制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (5) | CN104189949B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105582365A (zh) * | 2015-09-01 | 2016-05-18 | 牟少凤 | 一种适宜鼻出血患者使用的药膏及其制备方法 |
CN105288699A (zh) * | 2015-11-23 | 2016-02-03 | 青岛友诚高新技术有限公司 | 一种外用止血海绵及其制备方法 |
CN105650555B (zh) * | 2016-03-25 | 2018-06-19 | 安徽泽润光电有限公司 | Led面板灯及定位块 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62240621A (ja) * | 1986-04-11 | 1987-10-21 | Hokuriku Seiyaku Co Ltd | 止血剤 |
CN1539508A (zh) * | 2003-10-27 | 2004-10-27 | 武汉锐力科技有限公司 | 创面修复敷料基质、敷料及制备工艺 |
CN100453070C (zh) * | 2003-12-13 | 2009-01-21 | 昆明紫健生物技术有限公司 | 伤口止血消炎用无菌干粉喷剂及生产方法 |
CN101596207A (zh) * | 2008-06-04 | 2009-12-09 | 上海天龙药业有限公司 | 用于迅速止血的药用组合物及制备方法 |
CN101623350A (zh) * | 2009-07-09 | 2010-01-13 | 刘宁 | 一种快速止血粉 |
CN101647894B (zh) * | 2009-08-20 | 2011-02-16 | 荣伟 | 止血中药 |
CN102133340A (zh) * | 2011-03-16 | 2011-07-27 | 四川同人泰药业有限公司 | 一种外用中药创灼贴剂及其制备方法 |
CN103845418B (zh) * | 2014-03-25 | 2015-08-05 | 崔新明 | 一种治疗眼底出血的中药组合物及其用途 |
-
2014
- 2014-08-19 CN CN201410406936.4A patent/CN104189949B/zh active Active
- 2014-08-19 CN CN201510290072.9A patent/CN104857555A/zh active Pending
- 2014-08-19 CN CN201510290088.XA patent/CN104841003A/zh active Pending
- 2014-08-19 CN CN201510290087.5A patent/CN104840998A/zh active Pending
- 2014-08-19 CN CN201510290071.4A patent/CN104840997A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN104841003A (zh) | 2015-08-19 |
CN104840998A (zh) | 2015-08-19 |
CN104840997A (zh) | 2015-08-19 |
CN104857555A (zh) | 2015-08-26 |
CN104189949A (zh) | 2014-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100518794C (zh) | 烧伤膏 | |
CN102198159A (zh) | 一种治疗烧伤疮疡的药物及采用该药物制成的创面贴 | |
CN102309534B (zh) | 一种治疗烧烫伤的中草药组合物及其制备和应用 | |
CN101049466B (zh) | 治疗烧烫伤的中草药膏及其制备方法 | |
CN104189949B (zh) | 一种复方大蓟外用止血海绵及制备方法 | |
CN105194004A (zh) | 用于清洗伤口的消毒液的制备方法 | |
CN103417781B (zh) | 一种治疗外科伤口的中药 | |
CN103446240B (zh) | 一种快速愈合伤口的中药组合物 | |
CN104189947B (zh) | 用于外伤止血的海绵制剂及制备方法 | |
CN101204550B (zh) | 一种治疗癫痫的药物 | |
CN103263451A (zh) | 一种主治外伤、疮疡的中药及其制备方法和应用 | |
CN104623040A (zh) | 一种用于创口杀菌消炎的护理组合物及其制备方法 | |
CN100355437C (zh) | 一种治疗烧烫伤的药物及其制备方法 | |
CN103394009B (zh) | 一种治疗外伤和糠尿病足溃疡的中药及制备方法 | |
CN109045204A (zh) | 一种治疗烧伤和烫伤的中药液及其制备方法 | |
CN107583020A (zh) | 天然食材泡手脚粉的制备方法 | |
CN101934018B (zh) | 一种大面积烧、烫伤治疗用药物及其制备和使用方法 | |
CN102451249B (zh) | 一种治疗烧伤、烫伤的药物及其应用 | |
CN105232741A (zh) | 一种产后护理的中药组合物 | |
CN104127492A (zh) | 一种兼具止痛消炎功效的复方大蓟海绵及制备方法 | |
CN104208268A (zh) | 治疗急性损伤性皮肤伤的内服中药 | |
CN104027398A (zh) | 不留疤痕的烫伤外敷药 | |
CN108542956A (zh) | 一种药物组合物及其应用 | |
CN108653530A (zh) | 一种治疗烧、烫、冻伤的中药琥珀膏及其制备方法 | |
CN101279082A (zh) | 一种止痛的烧伤、烫伤、毒蜂蛰伤药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Han Dongwei Inventor after: Zhang Shaoliang Inventor after: Zhu Liming Inventor after: Luan Nianpeng Inventor after: Sun Zhongbo Inventor after: Han Xiumin Inventor after: Xue Yan Inventor after: Yue Jinjuan Inventor before: Zhang Xiuhua |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151022 Address after: 9 first people's Hospital of Development Zone, Huangpu Road, Qingdao economic and Technological Development Zone, Shandong 266000, China Applicant after: Han Dongwei Address before: 250014 Ji'nan Heping District, Lixia District, Shandong, Yanshan Applicant before: Zhang Xiuhua |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171011 Address after: 226100, 468, Xiushan West Road, Haimen street, Haimen, Jiangsu, Nantong Patentee after: Haimen Mingchi Industrial Design Co.,Ltd. Address before: 9 first people's Hospital of Development Zone, Huangpu Road, Qingdao economic and Technological Development Zone, Shandong 266000, China Patentee before: Han Dongwei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230914 Address after: 226000 Haimen Economic and Technological Development Zone, Nantong City, Jiangsu Province, No. 999 Guangzhou Road Patentee after: Nantong Construction Engineering Co.,Ltd. Address before: 226100 468 Xiushan Road, Haimen street, Haimen, Nantong, Jiangsu Patentee before: Haimen Mingchi Industrial Design Co.,Ltd. |